SCHEMBL7208378

SCHEMBL7208378

[CH2]Cc1ccc(OCc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.52
KMT2A Q03164 4/20 0.49
MEN1 O00255 2/20 0.49
ATM Q13315 1/20 0.49
C5AR1 P21730 1/20 0.49
MAPK1 P28482 2/20 0.47
MAPT P10636 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
BLM P54132 1/20 0.47
HSD17B10 Q99714 1/20 0.47
FOLH1 Q04609 1/20 0.46
POLB P06746 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8554816 0.90 MAPK1 (0.59) KMT2AMEN1MAPK1KDM4ENPC1
SCHEMBL8556952 0.90 MEN1 (0.60) KMT2AMEN1MAPTKDM4ENPC1
SCHEMBL9443940 0.84 NPC1 (0.55) KMT2AMEN1MAPK1MAPTTDP1
SCHEMBL2096298 0.84 SLC2A1 (0.51) SLC2A1KMT2AMEN1ATMC5AR1
SCHEMBL9025608 0.83 MTNR1A (0.52) SLC2A1KMT2AMEN1ATMC5AR1
SCHEMBL30821651 0.81 MAOB (0.58) SLC2A1KMT2AMEN1ATMC5AR1
SCHEMBL8657846 0.81 SLC2A1 (0.52) SLC2A1KMT2AMEN1ATMMAPK1
SCHEMBL30280404 0.81 SLC2A1 (0.56) SLC2A1KMT2AMEN1ATMC5AR1
SCHEMBL3236287 0.81 SLC2A1 (0.52) SLC2A1KMT2AMEN1ATMC5AR1
SCHEMBL584781 0.81 SLC2A1 (0.56) SLC2A1KMT2AMEN1ATMC5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922050-B1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LAB (US) 2003-07-30 EP claimed
EP-0922050-A1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1999-06-16 EP claimed
US-5750510-A ANTIBIOTICS ABBOTT LABORATORIES (US) 1998-05-12 US claimed
WO-1997042205-A1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1997-11-13 WO claimed
EP-0922050-B1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LAB (US) 2003-07-30 EP disclosed
EP-0922050-A1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1999-06-16 EP disclosed
US-5750510-A ANTIBIOTICS ABBOTT LABORATORIES (US) 1998-05-12 US disclosed
WO-1997042205-A1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1997-11-13 WO disclosed